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ABSTRACT
ESCHERICHIA COLI 2-OXOGLUTARATE DEHYDROGENASE
MULTIENZYME COMPLEX: E1 AND E2 SUBSTRATE SPECIFICTY, E1
CARBOLIGASE ACTIVITY, AND E2 INTERCHAIN SUCCINYL TRANSFER
by
Da Jeong Shim
Escherichia coli (E. coli) 2-oxoglutarate dehydrogenase multienzyme complex (OGDHc)
contains three components: a thiamin diphosphate (ThDP) dependent 2-oxoglutarate
dehydrogenase (E1o), a dihydrolipoylsuccinyl transferase (E2o), and a dihydrolipoyl
dehydrogenase (E3). The first two components carry out the principal reactions for
succinyl CoA formation while the third one reoxidizes dihydrolipoamide to lipoamide.
This mechanism is similar to other 2-oxoacid dehydrogenase complexes, including
pyruvate dehydrogenases (PDHc) and branched-chain dehydrogenases.
E1o of the E. coli OGDHc was engineered to accept unnatural substrates. The
natural substrate for E1o is 2-oxoglutarate (2-OG) and the enzyme was engineered to
accept substrates lacking the 5-carboxylate group, 2-oxovalerate (2-OV). E1o was
subjected to saturation mutagenesis at His260 and His298. The His298Asp E1o variant
was identified in the screen to accept the unnatural substrate.

In addition, it was

discovered that His260 is required for substrate recognition, but His298 could be replaced
with hydrophobic residues of similar molecular volume. To interrogate whether the
second component would allow synthesis of acyl-coenzyme A derivatives, hybrid
complexes consisting of recombinant components of OGDHc (o) and pyruvate
dehydrogenase (p) enzymes were constructed, suggesting that a different component is
the “gatekeeper” for specificity for these two multienzyme complexes in bacteria, E1p for
pyruvate but E2o for 2-OG.
i

Although His298Asp E1o accepted 2-OV, reconstitution of the variant with E2o
and E3 did not generate NADH in the overall reaction using 2-OV. Hence, the reaction
may be hindered in the E2o component. E2o consists of an amino-terminal lipoyl domain
(E2oLD, 12 kDa), followed by a peripheral subunit binding domain (4 kDa) and a
succinyltransferase domain (E2oCD, 28 kDa). There are two possibilities for the failure
to form NADH. Reductive acylation is not occurring in the E2oLD or acyl transfer to
CoA is not taking place in E2oCD. His298Asp E1o, E2oLD, and 2-OV form butyrylated
E2oLD, which was shown by electrospray ionization mass spectrometry. Therefore, the
E2oCD domain necessitates optimization to produce acyl-CoA derivatives.
Succinyl transfer to the CD domain may occur through an intrachain or interchain
pathway. The E2oLD and E2o with a lysine to alanine substitution at position 43
(E2oK43A) were created by site directed mutagenesis. It is clearly shown that E2oLD
was capable of rescuing the crippled E2oK43A variant by measuring the NADH
production in the overall reaction. Therefore, an interchain mechanism is likely between
two different E2o subunits.
ThDP-dependent enzymes have the potential to be used for chemical synthesis.
These enzymes share a common feature in that they catalyze carboligase reactions. E1o
catalyzed carboligation products with a variety of substrates and acceptors that vary in
the size and functional groups. Structures of the products were confirmed with NMR. In
addition, high enantiomeric excess (ee) values were found for the products as shown by
chiral gas chromatography and CD spectroscopy. Finally, it was shown that E1o is
capable of forming stable esters.

This is important because when the carboligase

reactions produce -ketoacids, these products are unstable and prone to decarboxylation.
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CHAPTER 1
INTRODUCTION

1.1 2-Oxoglutarate Dehydrogenase Multienzyme Complex from Escherichia coli
The 2-oxoglutarate dehydrogenase multienzyme complex (OGDHc) catalyzes the
rate-limiting step in the citric acid cycle (Figure 1.1) [1, 2], which is the common pathway
for the oxidation of fuel molecules, including carbohydrates, fatty acids and amino acids.
In addition, neurodegenerative disorders, such as Alzheimer’s and Parkinson’s disease
[3-5], have been linked to inactivation of OGDHc in highly active tissues. OGDHc
catalyzes the formation of succinyl coenzyme A (CoA) according to Equation 1.1.

Figure 1.1 Citric Acid Cycle.
Source: Jeremy M. Berg, John L. Tymoczko, and Lubert Stryer “Biochemistry” fifth edition, Freeman, pp.
478. http://www.ncbi.nlm.nih.gov/books/NBK22427/figure/A2403/?report=objectonly.

1

2-oxoglutarate + CoA + NAD+ → succinyl CoA + CO2 + NADH

(1.1)

The OGDHc is composed of multiple copies of three components (Figure 1.2)
[6-9]: (1) A thiamin diphosphate (ThDP) dependent 2-oxoglutarate dehydrogenase (E1o,
105 kDa, EC 1.2.4.2, Figure 1.2 A). (2) A dihydrolipoylsuccinyl transferase (E2o, 45 kDa,
EC 2.3.1.6, Figure 1.2 B and C) and (3) A dihydrolipoyl dehydrogenase (E3, 55 kDa, EC
1.8.1.4). The first two components carry out the principal reactions for succinyl-CoA
formation while the third one reoxidizes dihydrolipoamide E2 to lipoamide E2. This
mechanism is similar to other 2-oxoacid dehydrogenase complexes, including pyruvate
dehydrogenase (PDHc) and branched-chain dehydrogenase (BCDHc) (Equation 1.2-1.5).

A.

B.

C.

Figure 1.2 Structure of E1o and E2o Components. A: Ribbon Diagram of Truncated E1o.
Histidine 260 and 298 are Shown as Red Spheres. B: Ribbon Diagram of the Lipoyl
Domain of E2o. Lys43 is Shown as Sticks. C: Ribbon Diagram of E2o Catalytic Domain.
The Carboxyl-binding Residue (Ser333) is Shown in Magenta. The Carboxylate-binding
Group (His348) is Shown in Red.
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The E1o component catalyzes the initial decarboxylation of the 2-oxoglutarate,
using ThDP as a cofactor (Equation 1.2), and then reductively succinylates a lipoyl group
bound to a lysine residue in E2o (Equation 1.3, Figure 1.2 B). E2o is a succinyl transferase
responsible for transferring the succinyl group to CoA (Equation 1.4), and the
dihydrolipoyl group left on E2o finally reoxidized to the dithiol ring by the flavoprotein
E3, with NAD+ as the ultimate electron acceptor (Equation 1.5). The mechanism of
OGDHc and the role of ThDP are shown in Scheme 1.
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Scheme 1 Mechanism of 2-Oxoglutarate Dehydrogenase Complex of E. coli.

The OGDHc is organized about a core consisting of the oligomeric E2o [10-12],
which are bound to multiple copies of E1o and E3. The E2o component is a modular
protein that is composed of one, two, or three amino-terminal lipoyl domains, followed by
an E1o and/or E3-binding domain, and then by carboxyl terminal catalytic domain. The
domains are connected by linker segments [13-15]. In E. coli, E2o contains only one lipoyl
domain, subunit binding domain, and catalytic domain (Figure 1.3). The E2o is organized
either as a 24-mer with octahedral symmetry or a 60-mer with icosahedral symmetry
depending on the organism. The optimal stoichiometry for the E. coli complex has been
estimated at 12 E1o: 24 E2o: 12 E3 (3120 kDa) [16]. The E3 component is identical in
OGDHc and the pyruvate dehydrogenase complex (PDHc) [17, 18]. PDHc is also part of
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the citric acid cycle. PDHc shares a similar mechanism with OGDHc, but it utilizes
pyruvate as a substrate.

Figure 1.3 The E. coli E2o Component.

1.2 Substrate Specificity of OGDHc
Substrate specificity of OGDHc is regulated by E1o component as well as E2o. E1o is
responsible for recognition and decarboxylation of 2-oxoglutarate (2-OG) (Equation 1.2,
Figure 1.4 A). The crystal structure for a truncated E1o from E. coli (Figure 1.2 A) has
been reported [6]. Site directed mutagenesis and kinetic studies indicated that His260 and
His298 were positioned to interact with the distal carboxylate of 2-OG (Figure 1.5).

A.

B.

O

O

HO

O

OH

OH

O

O

2-oxoglutarate (2-OG)

2-oxovalerate (2-OV)

Figure 1.4 Substrates for OGDHc. A: Structure of 2-Oxoglutarate. B: Structure of
2-Oxovalerate.
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Figure 1.5 Stereo View Showing Histidines and a Few Other Residues near the Active Site
of the E. coli 2-Oxoglutarate Dehydrogenase Multienzyme Complex E1 Component,
Showing Their Proximity to the Reactive Center C2 Atom on Thiamin diphosphate
(ThDP). Coordinates for the Protein Atoms were Obtained from the PDB entry 2JGD,
which is Described in [6].
E2o substrate recognition occurs in two stages. First, E1o reductively succinylates
the prosthetic group lipoic acid that is covalently attached to Lys43 in the lipoyl domain
(Equation 1.3, Figure 1.2 B). An important interaction is between the E1 component and
the loop region of E2o. Key residues include 7-20 and Thr42 [17]. Second, the catalytic
domain (CD) of the E2o component catalyzes the transfer of a succinyl group from the
S-succinyldihydrolipoyl moiety to coenzyme A. Computational modeling and sequence
alignment studies of all known E2’s indicate that in E2o serine residues 330 and 333 are
located near the proposed succinyl-binding site. Ser333 may hydrogen bond with the
carboxyl group of the substrate. His348 is conserved in all E2’s, and it is positioned to
interact with the carboxylate oxygen of the succinyl group (Figure 1.6) [7]. The origin of
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substrate specificity remains unclear. It will be determined that the contribution of His260
and His298 for substrate specificity. In addition, the “gate-keeper” will be determined. For
example, does E1 or E2 control the substrate specificity?

Figure 1.6 The Stereo View of the Substrate Binding Sites on E2o Component [7].
1.3 Applications of OGDHc
1.3.1 Green Chemical Synthesis with OGDHc
Enzymes catalyze reactions under mild conditions in aqueous solutions, and they can also
provide tools for environmental friendly chemical synthesis [2, 19-21]. However,
biocatalysts often display poor catalytic activity for unnatural substrates. This is especially
true for enzymes that have specific functions across many species [22]. In addition,
enzymes are readily denatured under typical reaction conditions, which include organic
solvents and elevated temperatures. Hence, an efficient strategy is necessary to engineer
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enzymes, and semi-rational methods offer an effective approach to engineer and optimize
catalytic activity [23].
OGDHc has the potential to synthesize coenzyme A-linked thiol esters, comprising
a large class of metabolically relevant compounds participating in many metabolic
pathways. Also, thiol esters are important as organic synthetic intermediates by virtue of
the ‘high energy’ bound between the carbonyl group and the sulfur atom, and they can be
converted to a number of carboxylic acid derivatives [24]. It can also be used for peptide
coupling [25-27], acyl transfer [28, 29], protecting groups for thiols [30], and also as
coupling partners in organometallic reactions [31-33]. They are also key intermediates in
various biological systems [34] and find broad applications in medicinal chemistry [35].
There are many traditional methods for the formation of thiol esters, such as, the
direct coupling of a thiol with the parent carboxylic acid and an activating agent [36, 37],
the coupling of a thiol with an acid chloride [38], or reaction of thiol with an acid anhydride
[39] and the coupling of thiocarboxylates with arenediazonium salts [40]. However, there
are limitations of these methods such as difficulties in handling thiols and thioacids and
also the availability of starting materials. Thus, it is necessary to find a novel method for
such highly useful organic products.
It is proposed that the synthesis of thiol esters using a multi-enzymatic pathway to
convert a racemic amino acid precursor RCH(NH2)COOH, which are readily available, to
thiol esters RC(=O)SR’, with a broad range of R and R’ groups under mild neutral aqueous
conditions (Figure 1.7, reaction 1). First, a broad-spectrum racemase (EC 5.1.1.10) will
catalyze the stereochemical inversion around the asymmetric carbon atom (Figure 1.7,
Reaction 2). Next, a transaminase (EC 2.6.1.1) will catalyze the removal of the amino
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group to yield a 2-oxo acid (Figure 1.7, Reaction 3). The product will be decarboxylated by
E1 (Figure 1.7, Reaction 4), and E2 transfers to acyl group to a thiol (Figure 1.7, Reaction
5).
E1o will be engineered to accept non-natural substrate. E1o will be converted to
accept 2-oxovalerate over 2-oxoglutarate. The substrates are similar, but the carboxylate is
substituted by a methyl group (Figure 1.4).

Overall reaction:
NH2

O
OH

R

R

SR'

(1)

O
Individual reactions:

NH2
R

NH2

PLP-dependent

OH

R

racemase

O

transaminase

R

O

(3)

O

O

ThDP-dependent

OH
O
O

R

OH

O

PLP-dependent

OH

R

(2)

O

NH2
R

OH

decarboxylase
by E1

O
R

Acyl transferase

ThDP

to thiol by E2

ThDP

O
R

(4)

(5)
SR'

Figure 1.7 A Method to Convert a Racemic Amino Acid Precursor to Thiol Esters.
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1.3.2 Carboligase Reactions of OGDHc
The evolutionary pressure for optimized and efficient turnover has resulted in enzymes
with tight substrate specificities. However, most enzymes catalyze off pathway side
reactions caused by substrate and catalytic promiscuity [41-43].
This promiscuity has become very popular in point of redesigning and optimizing
enzymatic activities for industrial application [44, 45]. There are huge challenges to make
an existing enzymatic side reactions (low activity) become higher than its original activity
or introduce desired new activity without spoiling the original enzymatic activity [46].
The thiamin dependent enzymes, pyruvate decarboxylase and benzoylformate
decarboxylase, are well known enzymes for biocatalytic applications owing to their
inherent substrate and catalytic promiscuity. In addition to the decarboxylation of
2-oxoacids, ThDP-dependent decarboxylases, including the first components of the
2-oxoacid dehydrogenases catalyze so-called carboligation side reactions to form C-C
bonds [47, 48]. Conversion of the substrate 2-oxo acids involves a series of
substrate-cofactor conjugates as reaction intermediates (Scheme 1). Initially, addition of
the reactive C2 atom of the cofactor thiazolium ring to the carbonyl carbon of 2-oxoacids
yields

the

decarboxylation

pre-decarboxylation
produces

the

intermediate
resonating

C2-lactyl-ThDP.

C2-carbanion/enamine

Subsequent
forms

of

C2-hydroxyethylidene-ThDP, a central and highly reactive intermediate. A carboligase
side reaction takes place when the nucleophilic C2-carbanion/enamine adds to
electrophilic aldehydes or ketones [19, 47].
ThDP-dependent enzymes have the potential to be used for chemical synthesis.
Carboligation is the native activity for several enzymes, but it is a side reaction for nearly
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all 2-oxo acid decarboxylases [19]. Previously several active site variants were created in
yeast pyruvate decarboxylase (YPDC) from Saccharomyces cerevisiae, the E1 subunit of
E. coli PDHc (E1p) [49] and PDHc from Zymomonas mobilis [46]. Those enzyme
complexes produced different enantiomeric selective carboligase products using amino
acid analogs as the substrates [48, 50]. It can be used to synthesize important chemical
intermediates such as chiral 2-hydroxy ketones. The 2-hydroxy ketone products produced
from this activity afford versatile, exchangeable chemical groups in the immediate vicinity
of a chiral center. Valuable potential building blocks for the synthesis of numerous
compounds with pharmacological importance include: the tranquilizer and smoking
cessation drug bupropion [51], the anti-allergic drug cytoxazon [52], and the
multidrug-pump inhibitor 5-methoxyhydnocarpin [53]. Furthermore, carboligase products
can be used to treat health issues such as Alzheimer’s disease because they can inhibit the
citric acid cycle [49, 50]. This research will explore the possibility of using E1o for
carboligase reactions with 2-OG and various acceptors.

1.4 Importance of Recombinant 2-Oxoglutarate Dehydrogenase Complex
In 1985, the activity of OGDHc of E. coli was measured by Steginsky et al [54]. Their
results showed that OGDHc utilizes pyruvate as a poor substrate, with an activity of 0.083
units/mg protein compared with 22 units/mg protein for 2-OG. Activity with pyruvate
could result from the presence of contaminating PDHc or acceptance of pyruvate as a poor
substrate 2-OGDHc. They concluded that activity on pyruvate cannot be explained by
either of the above, but rather that the 2-OGDHc is a hybrid complex containing a
significant amount of the E1p component from E. coli PDHc. They separated those two
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enzyme complexes using their isoelectric precipitation (PI). There was a problem to
separate those two enzyme complexes because they have very similar PIs. These results
did not provide a clear origin of substrate specificity. Hence, it is important to use
recombinant proteins to ensure there is no contamination. This is necessary to understand
the true origin of substrate specificity of the complex.
In this work [55], all of the recombinant E1p, E2p, E1o, E2o and E3 components
were prepared as pure enzymes from E. coli. Each component will be reconstituted to
measure its overall activity so that the origin of substrate specificity can be clearly
elucidated.

1.5 Interchain Succinyl Transfer in the E2 Component of the E. coli 2-Oxoglutarate
Dehydrogenase Complex
The structural core of the complex is provided by E2, with E1 and E3 bound around the
periphery [14, 15, 56, 57]. The E2 chains are highly segmented, from the N-terminus, one
to three lipoyl domains (LD, approx. 9kDa), a peripheral subunit-binding domain (PSBD,
approx. 4kDa) and a catalytic domain (CD, approx. 28kDa) (Figure 1.3) [15, 58]. The E2o
chain of 2-OGDHc contains a single LD and an assembly of 24 separate CD arranged with
octahedral symmetry forms the core of the complex [7, 17], and it is possible that
interchain acyl transfer would take place between an LD of one chain and a CD of another
one, with the mobility of the LD provided by flexible alanine and proline rich extended
linkers.
Recently, the Jordan group at Rutgers investigated whether the acetyl group is
passed from the LD to the CD in an intra- or interchain reaction using E2p from E. coli
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PDHc, which contains three lipoyl domains [59]. They demonstrated interchain transfer of
the acetyl group by providing mass spectrometric and kinetic evidences. These data
provided a model for the presence of multiples of three chains in all E2 components, and
their assembly in bacterial systems. They created a hybrid single lipoyl domain instead of
using the natural three-lipoyl domain E2 component. Although it was shown that the
activities of one-LD E2p and three-LD E2p are virtually the same, it is possible that the
mutated single LD E2p can affect the results. Therefore, it is better to use native E2
component itself. As previously mentioned, the E2o from E. coli has only a single lipoyl
domain. This system is simpler and it should be easier to determine if interchain transfer is
a possible mechanism.

1.6 Research Objectives in This Dissertation
1. Elucidate the origin of substrate specificity in E. coli OGDHc and PDHc.
2. Determine the versatility of E. coli E1o for carboligase reactions.
3. Investigate interchain succinyl transfer of the E2o component of E. coli OGDHc.
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CHAPTER 2
ALTERING SUBSTRATE SPECIFICITY OF THE Escherichia coli E1o OF
2-OXOGLUTARATE DEHYDROGENASE COMPLEX

2.1 Introduction
The factors that govern specificity of 2-oxoglutarate dehydrogenase multienzyme complex
(OGDHc) towards its 5-carboxyl substituent will be elucidated. The goal is to synthesize
acyl-coenzyme A analogs, comprising a large class of metabolically relevant compounds
participating in many metabolic pathways.
According to the x-ray structure of E1o, there were three His residues (His260,
His298 and His729) positioned near the thiazolium ring of thiamin diphosphate (ThDP) [6]
(Figure 2.1), and substitution of His260 and His298 to alanine drastically reduced the
activity. The results suggested that the histidine side chains interacted with the distal
carboxylate of 2-oxoglutarate (2-OG) [6].

Figure 2.1 Active Site of E1o Showing Mg2+, ThDP, and the Inhibitor Oxaloacetate [6].

14

Saturation mutagenesis libraries of His260, His298, and His260/His298 were
created and screened for activity towards 2-OG, and an unnatural substrate, 2-oxovalerate
(2-OV), in which a nonpolar methyl group replaced the charged carboxylate (Figure 2.2).

A.

B.

O

O

HO

O

OH

OH

O

O

2-oxoglutarate (2-OG)

2-oxovalerate (2-OV)

Figure 2.2 Substrates for OGDHc. A: Structure of 2-Oxoglutarate. B: Structure of
2-Oxovalerate.
Several E1o variants were isolated, some with the ability to decarboxylate 2-OV.
The E1o variants created by the His260 and His298 substitutions were shown to be
functionally competent according to their ability to produce a ThDP-bound
pre-decarboxylation intermediate [60]. Next, it was determined whether the second E2o
component would allow synthesis of acyl-coenzyme A derivatives. Hybrid complexes
consisting of recombinant components of the E. coli 2-oxoglutarate (o) and pyruvate
dehydrogenase (p) enzymes were constructed (the E3 component is common to both) and it
was demonstrated that E1p imparts specificity for acetyl-CoA formation from pyruvate,
but E2o controls specificity for succinyl-CoA formation by OGDHc in Gram-negative
bacteria.
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2.2 Materials
Thiamin diphosphate (ThDP), dithiothreitol, and isopropyl--D-thiogalactopyranoside
(IPTG) were from U.S. Biochemical Corp.

NAD+, coenzyme A (CoA), and 2,

6-dichlorophenolindophenol (DCPIP) were from Sigma-Aldrich. Restriction enzymes
were purchased from Invitrogen. Primers were procured from Fisher.
E. coli strain JW0715 containing the plasmid pCA24N encoding the OGDHc-E1
(E1o) component and AG1 cells containing pCA24N plasmid encoding OGDHc-E2o [both
ASKA clone (-)] were obtained from National Bio Resource Project (NIG, Japan).

2.3 Methods
2.3.1 Site Directed Saturation Mutagenesis
Site-directed saturation mutagenesis libraries were constructed using a modified
QuikChange procedure for His260, His298, and the doubly substituted His260/His298
variants. A typical 50 L reaction contained 10x PfuUltra buffer, dNTP (0.2 mM) and
PfuUltra DNA polymerase (1 unit), pCA24N encoding the E1o subunit, and randomization
primers are shown in Table 2.1.

Table 2.1 List of NNS Primers
No
1
2
3
4

Site
5’
H260X-F
H260X-R
H298X-F
H298X-R

NNS Primers
CGGGATGGCGNNSCGTGGTCGTC
GACGACCACGSNNCGCCATCCCG
CGTGAAATACNNSATGGGCTTCTCG
CGAGAAGCCC ATSNNGTATTTCACG
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3’

The PCR reaction consisted of 18 cycles at 95 °C for 30 s, 55 °C for 1 min and 68
°C for 10 min. After the PCR, DpnI was added to the reaction mixture and then PCR
product was transformed into E. coli DH5 cells. In order to randomize both positions, the
template was the PCR product from H298 randomization and primers were H260X-F and
H260X-R (Figure 2.3).

Figure 2.3 PCR Strategy for Creating Site Directed Saturation Mutagenesis for H260X,
H298X, and H260X/H298X.

2.3.2 E1o Specific Assay
The E1o specific activity assay was adapted to measure activity in whole cell lysates in
96-well microtiter plates (Figure 2.4). The plasmids containing the mutant genes for
H260X, H298X or H260X/H298X were transformed into DH5 competent cells and
plated onto LB agar plates containing chloramphenicol (100 g/mL). Single colonies were
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picked into 96-well microtiter plates containing 200 L LB medium and chloramphenicol
(100 g/mL). The first column contained wild-type E1o as control. The plates were
incubated overnight at 37 °C in the shaker at 250 rpm. The master plates were duplicated
using 96-slot pin multi-blot replicator and it was stored at 4 °C. The duplicate plates
contained 200 L LB medium supplemented with chloramphenicol (100 g/mL), MgCl2
(2 mM), thiamin hydrochloride (1 mM) and IPTG (1 mM). The resulting plates were
incubated overnight at 37 °C with shaking at 250 rpm. Next, the plates were centrifuged
(1600 g) and the medium was discarded. The cell pellets were resuspended with 200 L
NaH2PO4 (100 mM, pH 7.0) containing ThDP (1 mM), MgCl2 (2 mM), lysozyme (1
mg/mL), and DNaseI (0.1 g/mL). The plates were incubated at 37 °C for 30 min and
centrifuged (1600 g). The supernatant was assayed for enzymatic activity (Figure 2.4).

Figure 2.4 E1o Specific Screen for Alter Substrate Specificity.
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E1o-specific activity was assessed using the external oxidizing agent
2,6-dichlorophenolindophenol (DCPIP) (Figure 2.5); its reduction was measured at 600
nm. The assay mixture contained: 110 L NaH2PO4 (100 mM, pH 7.0), DCPIP (0.1 mM),
MgCl2 (2.0 mM), ThDP (1.0 mM), and 2-oxoglutarate (2.0 mM, 2-OG) or 2-oxovalerate
(4.0 mM, 2-OV). The reaction was initiated by the addition of 40 L of supernatant, and
active variants were identified from the disappearance of the blue color upon DCPIP
reduction. The endpoint absorbance was measured using the microtiter plate reader at 600
nm at 30 °C. A rescreen was performed to eliminate false positives. Each positive clone
was retrieved from the master plate and it was streaked on LB agar plates containing
chloramphenicol (100 g/mL). Single colonies from each clone were picked into a column
of wells in a microtiter plate, and one column was reserved for the wild-type E1o. The
rescreen was similar to the E1o assay described above. The positive clones for 2-OG or
2-OV were sequenced using ABI BigDye Terminator chemistry on an ABI 3130xl genetic
analyzer (Molecular Resource Facility, University of Medicine and Dentistry of New
Jersey, Newark).

N

H
N

Cl

Cl

+ 2H+ + 2eHO

O

HO

Cl
2,6-dichlorophenolindophenol (Blue)

OH
Colorless

Cl

Figure 2.5 E1 Specific Colorimetric 2,6-Dichlorophenolindophenol Reduction Reaction.
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2.3.3 Expression and Purification of Wild Type E1o and Its Variants
An E. coli AG1 frozen stock harboring the E1o plasmid was streaked on LB agar plates
containing chloramphenicol (100 g/mL) and incubated at 37 °C overnight. A single
colony was used to inoculate 20 mL LB containing chloramphenicol (100 g/mL). The
overnight culture was used to inoculate 1 L of LB medium containing chloramphenicol
(100 g/mL), thiamin hydrochloride (1.0 mM), and MgCl2 (2.0 mM). The culture was
induced with IPTG (1.0 mM) at OD595 = 0.5-0.8 and incubated at 30 oC with shaking
overnight. The cells were centrifuged at 4400 g at 4 °C, and the pellet was stored at -20 °C.
All subsequent steps were carried out at 4 °C. The cells were resuspended in 20 mM
KH2PO4 (pH 7.0) containing NaCl (0.1 M), MgCl2 (2.0 mM), ThDP (1.0 mM),
benzamidine hydrochloride (1.0 mM), PMSF (1.0 mM), lysozyme (0.6 mg/mL) and
incubated on ice for 20 min. The cells were sonicated for 4 min (10 s pulsar “on” and 10 s
pulsar “off”) using the Sonic Dismembrator Model 550 (Fisher Scientific). The lysate was
centrifuged at 30,000 g at 4 °C for 30 min. The supernatant was applied to a Ni Sepharose
6 Fast Flow Column (GE Healthcare) that was equilibrated with KH2PO4 (20 mM, pH 7.4),
which contained NaCl (0.1 M), MgCl2 (2 mM), ThDP (1 mM), benzamidine hydrochloride
(1 mM). The enzyme was eluted with KH2PO4 (20 mM, pH 7.4) containing NaCl (0.5 M),
imidazole (150 mM), MgCl2 (2.0 mM), and ThDP (1.0 mM). Fractions with enzyme were
combined, dialyzed against KH2PO4 (20 mM, pH 7.4) containing MgCl2 (2.0 mM), ThDP
(1.0 mM) and benzamidine hydrochloride (1.0 mM). Next, the enzyme was concentrated
by ultrafiltration with a cutoff of 30 kDa. The purity was confirmed by SDS-PAGE. The
E1o variants were overexpressed and purified using the procedure developed for wild-type
E1o. Wild-type E1o and E1o variants were stored at -20 °C.
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2.3.4 Expression and Purification of Wild-type E2o
A single colony on the plate was used to inoculate 16 mL LB containing chloramphenicol
(30 g/mL). Next, the overnight culture was inoculated into LB (800 mL) containing
chloramphenicol (30 g/mL) and lipoic acid (0.3 mM), and cells were grown at 37 °C to an
OD650 = 0.6 - 0.7. The E2o expression was induced by IPTG (0.1 mM) for 5 h at 37 °C.
Cells were collected, washed with KH2PO4 (20 mM, pH 7.0) containing NaCl (0.15 M) and
stored at -20 °C.
The E2o was purified, as was E2p [61] with some modifications. The precipitation
of E2o by ammonium sulfate was replaced by ultracentrifugation at 117000 g for 4 h. E2o
was purified using Sephacryl S-300 HR gel-filtration column equilibrated with 20 mM
KH2PO4 (pH 7.2) containing 0.50 mM EDTA, 0.20 M NaCl, 1 mM DTT and 1 mM
benzamidine HCl. Fractions containing E2o were collected and protein was precipitated
by ultracentrifugation as described above. The pellet was dissolved in 20 mM KH2PO4
(pH 7.2) containing 0.50 mM EDTA, 1 mM DTT, 1 mM benzamidine HCl and 0.50 mM
NaCl (the concentration of NaCl was increased from 0.2 M to 0.5M to keep protein
soluble). E2o was stored at -80 oC. Expression and purification of wild type E3 was carried
out according to Wei et al. [62].
2.3.5 Activity and Related Measurements
The E1-specific activity of wild type E1o and its variants was measured by monitoring the
reduction of DCPIP at 600 nm using a Varian DMS 300 or DMS 500 spectrophotometer.
The assay medium contained in KH2PO4 (20 mM, pH 7.0): MgCl2 (2 mM), ThDP (0.2
mM), DCPIP (0.1 mM) and substrate [2-OG (2 mM), pyruvate (25 mM) or 2-OV (45 mM)]
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at 30 °C. The reaction was initiated by adding the enzyme. One unit of activity is defined as
the amount of DCPIP reduced (mol/min/mg of E1o).
The overall activity of the OGDHc was determined from the substrate-dependent
reduction of NAD+ at 340 nm after reconstitution for 20 min at 25 °C of E1o with E2o and
E3 at a mass ratio of 1:1:1 (mg/mg/mg) in 20 mM KH2PO4 (pH 7.2) containing 0.15 M
NaCl. The assay medium contained: 0.1 M Tris-HCl (pH 8.0), MgCl2 (1.0 mM), ThDP
(0.2 mM), dithiothreitol (2.6 mM), NAD+ (2.5 mM), and substrate [2-OG (2 mM) or
pyruvate (25 mM) or 2-OV (45 mM)]. The reaction was initiated by the addition of CoA
(0.13 mM). The initial steady state velocities were determined from the progress curves
recorded at 340 nm and 30 °C. One unit of activity is defined as the amount of NADH
produced (mol/min/mg of E1o). The reaction conditions for the hybrid E1o-E2p-E3 and
E1p-E2o-E3 complexes were the same. It should be noted that the E3 component is
common to PDHc and OGDHc from E. coli [17, 18].
2.3.6 Circular Dichroism (CD) Measurement
CD experiments were carried out on a Chirascan CD spectrometer (Applied Photophysics,
Leatherhead, UK) at 30 °C by using the pyruvate and 2-OG analogs sodium
acetylphophinate

(AcP-)

[63],

methyl

acetylphosphonate

(MAP-)

[64],

propionyl-phosphinate (PP-), succinylphosponate (SP2-) and succinylphosphonate methyl
ester (SPME-) (Appendix). E1o and its variants (concentration of active centers = 20 -24
M) in 20 mM KH2PO4 (pH 7.0) containing NaCl (0.15 M), MgCl2 (2.0 mM) and ThDP
(0.2 mM) were titrated with substrate analogs (0.5 – 2000 M). The difference CD spectra
were obtained by subtracting the CD spectrum of E1o or its variants in the absence of
substrate analogs. The values of Kd were determined as described earlier [65].
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2.3.7 Sample Preparation for Fourier Transform Mass Spectrometric Analysis
(FTMS)
Electro-spray ionization FTMS was performed with an Apex-ultra 70 hybrid FTMS
instrument from Bruker Daltonics (Billerica, MA). The E1p-E2o-E3 or E1o-E2p-E3
hybrid complexes were reconstituted by the same method as above. Sequentially, the
complexes were incubated for 10 min in the reaction medium containing: Tris-HCl (0.1 M,
pH 8.0), MgCl2 (1.0 mM), ThDP (0.2 mM), dithiothreitol (2.6 mM), NAD+ (2.5 mM), CoA
(0.13 mM) and 2-OG (2 mM) or pyruvate (2 mM) at 25 oC. To quench the reaction and
precipitate protein an acidic quench solution consisting of 12.5% trichloroacetic acid/1 M
HCl was added. After the acid quench, protein was removed by centrifugation at 15,700 g
for 15 min. For control, acetyl-CoA, succinyl-CoA and CoA stock solutions were prepared
in deionized water and diluted to 0.13 mM in acidic quench solution. Then, 50 L of each
sample was mixed with 50 L of solvent containing 0.1 % (v/v) formic acid and 50 %
MeOH (v/v) in deionized water. These samples were then injected into FTMS at 2 L/min;
20 scans were acquired with a netflow rate of 1.0.
To further confirm the ability of E1o to accept pyruvate and use it in reductive
acetylation of E2p, a mixture of E1o + pyruvate + lipoyl domain E2p (N-terminally
His-tagged and purified to homogeneity on a Ni-Sepharose column) was used. Then
quenched the mixture was quenched into acid quench solution and ran the ESI-FTMS on
the product. Mass corresponding to reductively acetylated dihydrolipoyl domain E2p or
succinylated dihydrolipoyl domain E2p was observed.
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2.4 Results
2.4.1 Screening
Results of screening revealed that of the 352 colonies screened for His260 substitutions, 7
were found positive with 2-OV and 61 with 2-OG. Of the 7 colonies found positive for
2-OV, DNA sequencing revealed that all were wild-type E1o. Of the 8 colonies screened
positive with 2-OG, 7 were identified as wild-type E1o and one was His260Glu. This
immediately suggests that His260 is crucial for substrate binding. At position His298, 440
colonies were screened for 2-OG activity and 350 for 2-OV activity. DNA sequencing
identified the His298Thr and His298Leu substitutions active with 2-OG, and the
His298Asp and His298Val substitutions active with 2-OV. Screening for dual
His260/His298 substitutions with 2-OG (1232 colonies) and with 2-OV (1672 colonies)
revealed several active variants: His260/His298Thr (with 2-OG), His260/His298Asp,
His260/His298Thr, and His260Glu/His298Asn (with 2-OV) (Table 2.2).
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Table 2.2 Mutations from NNS Libraries
Number of
sequenced
colonies

Wild –type
identified

Substitutions

61

7

6

Glu

352

6

0

0

none

His298 + 2-OG

440

154

6

3

Thr(2), Leu

His298 + 2-OV

352

65

3

0

Gly, Asp, Val

His260/His298 + 2-OG

1232

65

8

7

His260/Thr298

0

His260/Gly298(2)
His260/Asp298(3)
His260/Thr298(1)
Glu260/Asn298(1)

Screening

Number of
colonies
analyzed

Number of
positive
colonies

His260 + 2-OG

352

His260 + 2-OV

His260/His298 + 2-OV

1672

306

7

25
25

2.4.2 The E1-specific activity
The E1-specific activity was unaffected when E1o was reconstituted into E1o-E2o-E3 or
E1o-E2p-E3 complexes. Similar E1-specific activity was found with 2-OG, pyruvate or
2-OV using E1o by itself or assembled in the OGDHc or hybrid (E1o-E2p-E3) complex
(Table 2.3 A). The activity of E1o was 24% towards pyruvate and 19% towards 2-OV
compared to 2-OG. The E1-specific activity in complex reconstituted from E1o and the
E2o and E3 components (36% with pyruvate and 21% with 2-OV) remained similar to that
with E1o by itself. Reconstitution of E1o in the hybrid complex with E2p and E3, led to an
E1-specific activity of 34% with pyruvate and 23% with 2-OV. This indicated that
assembly into the OGDHc or hybrid complex does not affect significantly the E1-specific
rates (Table 2.3 A). These results gave important evidence that pyruvate and 2-OV were
substrates for E1o, as the DCPIP reduction assay clearly indicates that decarboxylation has
taken place. No overall activity was detected with pyruvate or 2-OV for either the OGDHc
or the hybrid E1o-E2p-E3 complex. The E1o-E2p-E3 hybrid complex exhibited detectable
activity (2.2%) with 2-OG. In contrast to E1o, E1p displayed activity only with pyruvate.
In the DCPIP assay, E1p by itself showed no activity towards 2-OG or 2-OV.
Furthermore, there was no activity for 2-OG or 2-OV for E1p reconstituted with either E2p
+ E3 or E2o + E3. Similar results were obtained in the overall activity assay (Table 2.3 B).
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Table 2.3 A: E1-specific and Reconstituted Complex Activity with E1o

Table 2.3 B: E1-specific and Reconstituted Complex Activity with E1p

To provide further evidence that pyruvate is indeed a substrate for E1o, these
studies were conducted. (1) The carboligase side reactions commonly accompany
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ThDP-catalyzed decarboxylations. These reactions involve nucleophilic addition of the
enamine to the carbonyl carbon of reactant or product, resulting in the formation of
acetoin-like or acetolactate-like ligated products (Scheme 2).

Scheme 2 Mechanism of Carboligase Reaction.

Observation of carboligase products provides strong confirmation that
decarboxylation of substrate had taken place. On addition of pyruvate to E1o, a negative
CD band developed at 300 nm, indicating formation of optically active (R)-acetolactate,
(Figure 2.6). The negative circular dichroism (CD) band at 300 nm was still present after
removal of protein; both the sign of the band and its location are similar to those observed
with the Glu636Ala variant of E1p ([50], confirmed on that enzyme both by CD and
NMR).

28

Figure 2.6 Near-UV CD Spectra of E1o in The Presence of Pyruvate. The E1o (13.2 M
Active Center Concentration) in 20 mM KH2PO4 (pH7.0) Containing 2.0 mM MgCl2 and
0.20 mM ThDP (curve 1). CD Spectra of E1o after Addition of 4 mM Pyruvate at Different
Times of Incubation (curves 2-10). Inset: The Dependence of the CD at 300 nm on Time of
E1o Incubation with 4 mM Pyruvate.

Next, it was next demonstrated that the pyruvate decarboxylated by E1o could
reductively acetylate lipoyl domain derived from E2p (LD-E2p), which could be detected
by Fourier Transform Mass Spectrometry (FTMS). The rate constant for reductive
acetylation of LD-E2p by (E1o + pyruvate) was 0.0056 + 0.001 s-1, compared to 51.7 + 5.4
s-1 for (E1p + pyruvate) under the same conditions. The reductive acetylation of the
didomain comprising lipoyl and subunit binding domains of the E2p was also
demonstrated (not shown). Formation of succinyl-CoA by E1o-E2o-E3 and 2-OG was
confirmed by both the isotopic pattern and m/z ratio (868.14) of a succinyl-CoA standard
in FTMS (Figure 2.7). Next, E1o-E2p-E3 was reacted with 2-OG to produce detectable
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amounts of succinyl-CoA (Table 2.3 A), displaying a similar isotopic distribution with the
standard spectrum of succinyl-CoA (Figure 2.8).

Figure 2.7 Mass Spectrum of Succinyl-CoA Standard (top) and as Produced by
E1o-E2o-E3 with 2-OG (bottom).
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Figure 2.8 Mass Spectrum of Succinyl-CoA Standard (top) and as Produced by
E1o-E2p-E3 with 2-OG (bottom).

These additional experiments, in part, were carried out to also address the finding
by Frey’s group that in the OGDHc isolated from E. coli, there is indeed found as much as
10% E1p [54], whose presence would confound our interpretation. It needs to be
demonstrated that the pyruvate-decarboxylating activity displayed by E1o was not an
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artifact of the presence of E1p. The fact that all of the components of OGDHc were
His-tagged and independently overexpressed together in the experiment above rules out
any significant contamination from intrinsic E1p components.
2.4.3 Effect of His260 and His298 Substitution of E1o Activity
The effect of His260 and His298 substitutions on E1o activity was examined. Saturation
mutagenesis data revealed that His298 could tolerate substitution. The DCPIP activity for
the E1o variants with 2-OG was ranged from less than 1% (His298Thr) to 19%
(His298Leu) (Table 2.4 A). The KM for 2-OG increased for some E1o variants, while the
catalytic efficiency (kcat/KM) of all variants with 2-OG was lowered.

The catalytic

efficiency for the best E1o variants decreased ~7-fold for His298Leu and ~17-fold for
His260Glu/His298Asn, and was severely compromised for other variants (Table 2.4 A).
Remarkably, the His298Asp and His298Val substitutions converted E1o to 2-OV
dehydrogenase with activities comparable to that observed with 2-OG (Table 2.4 B). The
His298 substitution in E1o also affected the overall OGDHc activity (Table 2.5). The
relative activities according to the E1-specific and overall activity assays were
approximately paralleled. Finally, OGDHc did not show any overall activity towards
2-OV, again implying discrimination at the E2o level.
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Table 2.4 Effect of His298 and His260/His298 Substitutions on E1-specific Activity of
OGDHc
A: 2-Oxoglutarate as Substrate
DCPIP activity

kcat

(mol.min-1.mg-1)

(s-1)

none

0.620 ±0.03a

2.15 ±0.10

2.61 ±0.376

824

His298Leu

0.120 ±0.028

0.415 ±0.098

3.41 ±0.237

122

0.0018 ±0.0001 0.0064 ±0.0002 4.25 ± 0.160

1.5

Substitution

His298Thr

KM

kcat/KM

-1
-1
(mM x 10-3) (s mM )

His298Asp

nd b

nd

nd

nd

His298Val

0.029 ±0.003

0.099 ±0.009

165 ±6

0.60

His260Glu/His298Asn

0.039 ±0.004

0.134 ±0.013

2.73 ±0.469

49.1

His260Glu

0.0091 ±0.0007

0.032 ±0.003

383 ±35.5

0.0084

a

E1o was from a different preparation than in Table 2. b Not detectable above the
background.

B: 2-Oxovalerate as Substrate
DCPIP activity

kcat

KM

kcat/KM

(mol.min-1.mg-1)

(s-1)

(mM)

(s-1 mM-1)

none

0.022 ±0.002

0.076 ±0.007

16.3 ±4.00

0.0047

His298Leu

0.027 ±0.003

0.094 ±0.011

6.30 ±0.64

0.015

His298Thr

0.0086 ±0.0009

0.030 ±0.003

15.3 ±1.00

0.0020

His298Asp

0.357 ±0.018

1.24 ±0.062

7.02 ±0.023

0.18

His298Val

0.160 ±0.005

0.556 ±0.018

8.96 ±0.005

0.062

His260Glu/His298Asn

0.017 ±0.0008

0.060 ±0.003

68.4 ±4.05

0.00088

His260Glu

0.0039 ±0.0001

0.014 ±0.0003

0.12 ±0.034

0.12

Substitution

.
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Table 2.5 Steady-state Kinetic Parameters for the Overall Activity of OGDHc Variants
with 2-OG
NAD+ activity

kcat

Km

kcat/Km

(mol.min-1.mg-1)

(s-1)

(mM)

(s-1 mM-1)

none

16.6  0.44

57.5  1.57

0.09  3.61

639

His298Leu

3.80  0.21

13.2  0.51

0.27  0.34

48.9

His298Thr

0.26  0.01

0.90  0.02

0.23  0.04

3.91

His298Asp

0.2 

0.79 

0.30

2.63

His298Val

0.28  0.03

0.98  0.09

0.15  0.01

6.53

His260Glu/His298Asn

0.28  0.01

0.97  0.03

0.22  0.02

4.41

His260Glu

0.40  0.01

1.39  0.02

0.72  0.01

1.93

Substitution

2.4.4 Analysis of Pre-decarboxylation Intermediate by Circular Dichroism
CD experiments revealed formation of a pre-decarboxylation intermediate analog between
E1o and 2-oxophosphonate and 2-oxophosphinate analogs (Figure 2.9). The Jordan group
at Rutgers has published extensively on CD detection of ThDP-bound covalent
intermediates on enzymes with substrate mimics derived from methyl acetylphosphonate
(MAP) and acetylphosphinate (AcP-), which are analogs of pyruvate (Figure 2.9) [60, 63,
66].
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Figure 2.9 Phosphonate and Phosphinate Analogs Used in Experiments.

It had been reported that succinyl phosphonate (SP2-) and its monomethyl
phosphonate ester (SPME-), which are analogs of 2-OG, inhibit partially purified OGDHc
complex from brain with S0.5,

SP

= 0.12 mM, which is in the range of values of KM, 2-OG

=0.1-0.2 mM reported for OGDHc from different sources [67]. The inhibitory effect of
SPME- was also demonstrated for OGDHc from E. coli and pigeon breast muscle [68] and
very recently for MenD [69]. MenD is also a thiamin diphosphate-dependent enzyme
involved in the biosynthesis of menaquinone in bacteria. Initially, E1o was titrated with
AcP- because this analog was found to bind strongly to a number of ThDP enzymes [60].
CD spectra of E1o titrated with AcP- revealed the generation of two CD bands: a positive
one at 297 nm earlier assigned to the 1’,4’-iminopyrimidine tautomer (IP) of the first
covalent intermediate and a negative one at 330 nm assigned to a Michaelis complex [66]
(Figure 2.10).
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Figure 2.10 Michaelis Complex and 1’,4’-Iminopyrimidine (IP)-ThDP Forms Detected by
CD.
The calculated values of Kd for AcP- were 320 M (at 297 nm) and 310 M (at 330
nm) (Figure 2.11, Table 2.6) as compared with KM,

2-OG

of 90 M (Table 2.5). Later,

SPME-, SP2- and PP-, analogs for 2-OG and 2-OV, respectively, were evaluated in the CD
experiment (Table 2.6, Figures 2.12 and 2.13).
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Figure 2.11 Circular Dichroism Titration of E1o by Acetyl Phosphinate. E1o (1.62
mg/mL, Concentration of Active Centers = 15.5 M) was Titrated by AcP- (5-800 M) in
20 mM KH2PO4 (pH 7.0) Containing 2 mM MgCl2 and 0.2 mM ThDP at 30 oC. Inset:
Dependence of the Ellipticity at 297 nm on Concentration of AcP-.
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Figure 2.12 Circular Dichroism Titration of E1o with Succinyl Phosphonate Methyl Ester.
E1o (2.5 mg/ mL, Concentration of Active Centers = 23.6 M) in 20 mM KH2PO4 (pH 7.0)
was Titrated by SPME- (1-200 M) in 20 mM KH2PO4 (pH 7.0) Containing 2 mM MgCl2
and 0.20 mM ThDP. Inset: Dependence of Ellipticity at 300 nm on the Concentration of
SPME-.
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Figure 2.13 Circular dichroism titration of E1o with propionyl phosphinate. E1o (2.39
mg/mL, concentration of active centers = 22.6 M) in 20 mM KH2PO4 (pH 7.0) containing
2 mM MgCl2, 0.20 mM ThDP and 1.5 mM NaCl was titrated by PP- (30-140 M). Inset:
Dependence of the ellipticity at 297 nm on concentration of PP-.
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Table 2.6 Circular Dichroism Determination of the Formation of Pre-decarboxylation
Intermediate between E1o Variants and Substrate Analogs

E1o substitution
wt
wt
wt
wt
wt
His298Leu
His298Leu
His298Thr
His298Thr
His298Asp
His298Asp
His298Val
His298Val
His260Glu/His298Asn
His260Glu/His298Asn
His260Glu
His260Glu

Substrate
analogs
AcPMAP
PPSP2SPMESPMEPPSPMEPPSPMEPPSPMEPPSPME PPSPME PP-

CD maximum (nm)

Kd (M)

297
No band detected
300
300
297
297
300
297
297
298
300
297
297
No band detected
305
No band detected
No band detected

320 ±52.2
39.0 ± 2.08
28.4 ±1.12
10.1±0.42
Not saturated
22.3 ±0.98
6.07 ±0.53
7.00 ±0.23
659 ±11.5
9.61 ±0.20
144 ±11.6
5.17 ±1.04
7.69 ±2.50
-

These are the first CD experiments to demonstrate that on addition of substrate
analogs, E1o forms a tetrahedral ThDP-bound pre-decarboxylation intermediate analog,
resembling those formed from substrates. The Kd values determined are in the M range
(SPME- phosphonate monoester gives the best Kd =10 M, while the di-acid SP2- is
approximately three times weaker) demonstrating that some of the tested compounds could
be powerful inhibitors of the OGDHc E1o component (Table 2.6). Similar CD experiments
with the His298 E1o variants by phosphonate and phosphinate analogs of 2-oxoacids
(Appendix) indicated that this substitution is not favorable for binding of SPME-,
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excepting His298Thr. For the His260Glu/His298Asn variant, no CD band was detected at
300 nm. On the other hand, His298 substitutions and the double His260Glu/His298Asn
substitution were favorable for binding of PP-, which is a substrate analog for 2-OV. The
His298Asp variant has a Kd value of 9.6 M as compared with 39 M for E1o (Figure 2.14,
Table 2.6). In general, the Kd, PP- were smaller (binding was stronger) than that for E1o, and
Kd, PP- ranged from 5.17–22.3 M (Appendix).

Figure 2.14 Circular dichroism titration of His298Asp with propionyl phosphinate. The
His298Asp E1o (2.5 mg/mL, concentration of active centers=23.8 M) in 20 mM KH2PO4
(pH 7.0) containing 2 mM MgCl2 and 0.2 mM ThDP was titrated by PP- (5-580 M).
Dependence of the ellipticity at 300 nm on the concentration of PP-.

2.5 Discussion
The following could be concluded about the roles of His260 and His298 in E1o. The
His260Glu, His298Thr, His298Val and His298Leu substitutions displayed activity with
2-OG. The His298Asp and His298Val substitutions led to active enzyme with 2-OV,
displaying improvement in kcat/KM in comparison to the E1o. While finding a positively
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charged or hydrophilic side chain in its place could be anticipated, the most active variant,
His298Leu is unexpected, with a KM comparable to that of E1o. Being only slightly larger
than histidine, this substitution to leucine may only fulfill a volume constraint (the van der
Waals volumes for leucine and histidine are 124 Å3 and 118 Å3, respectively). A study on
the active center residues of the ThDP enzyme benzoylformate decarboxylase led to a
similar conclusion on residue His281: it could be replaced by phenylalanine or leucine
without significant activity loss [70]. Randomization at His260 was yielded only one E1o
variant (His260Glu) with low activity toward 2-OG and much better activity towards
2-OV.
The active variants identified by E1-specific assay were shown to be functionally
competent according to their ability to form pre-decarboxylation covalent intermediate
analogs between the ThDP and phosphono- or phosphino- analogs of 2-OG and 2-OV as
judged by CD. The values of Kd calculated from CD data are in the M range as compared
with reported values of KM, 2-oxoglutarate = 0.1 - 0.2 mM [67], and point to increasing binding
potency with increasing chain length. For all His298 variants, PP- was more firmly bound
than SPME-, suggesting conversion of function from 2-oxoglutarate dehydrogenase to
2-oxovalerate dehydrogenase, especially with the His298Asp and His298Val variants,
which display relatively high activity with 2-OV. The single low activity His260Glu E1o
variant did not display measurable CD signal with PP- or SPME-, consistent with kinetic
analysis. The randomization experiment, kinetic study and CD detection of covalent
intermediate analogs provide strong evidence that His260 is crucial and indispensable for
2-OG recognition.
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Surprisingly, the E1o could decarboxylate 2-OV and pyruvate, in addition to 2-OG
according to the DCPIP assay, an assay adequate to confirm decarboxylation of the
substrates. To interrogate whether the second component would enable synthesis of
acyl-coenzyme A derivatives from substrates accepted by the engineered E1o, hybrid
complexes consisting of recombinant components of the E. coli OGDHc (o) and PDHc (p)
were constructed (the E3 component is common to both). On reconstitution of E1o with
E2o and E3 in OGDHc, the overall activity with 2-

-1

.mg E1o-1 and

correlated well with recently published data on E1o [6]. No NADH production was
detected with pyruvate or 2-OV in the E1o-E2o-E3 and E1o-E2p-E3 hybrid complexes.
Detection of succinyl-CoA formation by mass spectrometry, and of reductively acetylated
and succinylated LD-E2p, and of activity of the reconstituted complex by NADH kinetic
assay, allowed us to conclude that: (1) E1o-E2o-E3 and E1p-E2p-E3 produced the
respective acyl-CoA products and NADH; (2) E1o-E2p-E3 could produce succinyl-CoA
from 2-OG; (3) E1p-E2o-E3 could not produce acetyl-CoA from pyruvate; and (4) E1o
could reductively acetylate, and reductively succinylate LD-E2p. Apparently, a different
component is the ‘gatekeeper’ for specificity for acyl-CoA formation by these two
important multienzyme complexes in Gram-negative bacteria, E1p for pyruvate, but E2o
for 2-OG. The ability of E1o to reductively acetylate LD-E2p, and the ability of the hybrid
E1o-E2p-E3 to produce succinyl-CoA provide strong confirmation of this statement.
The principal difference between this and earlier work is that here recombinant
individual components were used, while earlier work used isolated complexes, PDHc and
OGDHc, or their sub-complexes. Notably, Frey and associates demonstrated that 10% E1p
co-purified with E. coli OGDHc, however, the overall activity was about 1% of that with
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PDHc, already suggesting that the E2o also conferred substrate specificity in terms of rates
[54]. deKok and coworkers used the OGDHc isolated from Azotobacter vinelandii and
found modest overall activity with pyruvate, but no E1-specific activity was detected, in
contrast to our findings [71]. ‘Promiscuous’ substrate utilization has been identified in
several ThDP enzymes: ‘engineering’ by single amino acid substitutions has been shown
to

lead

to

changing

both

substrate

and

reaction

specificity

from

a

decarboxylase/dehydrogenase activity to carboligase-like activity in yeast pyruvate
decarboxylase [72], E1p [50], benzoylformate decarboxylase [73, 74] among others; the
specificity of acetohydroxyacid synthase toward pyruvate as donor has been attributed to
hydrophobic residues [75].
These results rule out an acid-base or hydrogen-bonding role for the residue
His298, but confirm a hydrogen-bonding role for His260. Hence, to create complexes
capable of accepting alternate 2-oxoacids, it will also be necessary to engineer the E2o
active center.
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CHAPTER 3
THE E2 COMPONENT OF 2-OXOGLUTARATE DEHYDROGENASE
COMPLEX FROM ESCHERICHIA COLI ALSO DICTATES SUBSTRATE
SPECIFICITY, IN ADDITION TO THE E1 COMPONENT

3.1 Introduction
In Chapter 2, it was shown that the His298Asp E1o variant could accept the unnatural
substrate 2-oxovalerate (2-OV) at a faster rate than the natural substrate 2-oxoglutarate
(2-OG) (Figure 3.2).

A.

B.

Figure 3.1 Substrates for E1o. A: 2-Oxoglutarate (Natural Substrate). B: 2-Oxovalerate
(Unnatural Substrate).

Next, His298Asp E1o was reconstituted with E2o and E3 and the multienzyme
complex did not generate NADH in the overall reaction when using as 2-OV (Equation
3.1). Therefore, the overall complex failed to make the butyryl-CoA derivative.

2-oxovalerate + CoA + NAD+ → butyryl-CoA +CO2 + NADH
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(3.1)

The E2o component consists of an amino-terminal lipoyl domain (E2oLD, 12 kDa)
[17], followed by a peripheral E1o and E3 subunit binding domain (4 kDa) and a catalytic
domain (E2oCD, 28 kDa) (Figure 3.1).

Figure 3.2 Domains in E2o of OGDHc from E. coli.

There are two possibilities for the failure to form NADH from 2-OV. Substrate
specificity is determined at on two levels: reductive acylation is not occurring in the
E2oLD or acyl transfer is not taking place from E2oCD to CoA in E2oLD (Figure 3.3). It is
also possible that neither E2oLD nor E2oCD is capable of accepting the unnatural
substrate. The E. coli E2oLD crystal and NMR structures have been determined [7, 8]
(Figure 3.3). In addition, the structure of E2oCD has been solved.

A.

B.

Figure 3.3 A: Ribbon Diagram of the Lipoyl Domain of E2o (E2oLD). Lys43 is Shown as
Sticks. B: Ribbon Diagram of E2o Catalytic Domain (E2oCD). The Carboxyl-binding
Residue (Ser333) is Shown in Magenta. The Carboxylate-binding Group (His348) is
Shown in Red.
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Initially, the E1o component that contains the ThDP-bound post-decarboxylation
intermediate interacts with E2oLD, resulting in reductive acylation of the E2o-bound lipoic
acid. It is known that the lipoyl domains from the pyruvate dehydrogenase complex
(PDHc) and OGDHc complexes only function as efficient substrates for their respective
E1p and E1o components [76-78]. As a result, lipoyl domains may be critical to the
specificity of those multienzyme complexes.
The ability of E2oLD to undergo reductive acylation was first examined. If E2oLD
does not accept the substrate from E1o then E2oLD necessitates engineering. If E2oLD
does accept the substrate then E2oCD requires optimization. Experiments were designed to
test these possibilities. First, E1o will be incubated with E2oLD. It was previously shown
that wild-type E1o accepts 2-OV (Chapter 2). Then, 2-OV will be added and electrospray
ionization mass spectrometry (ESI-MS) will be performed to detect whether reductive
acylation has occurred. 2-OG will be used as a positive control. Second, the E1o will be
incubated with E2pLD from PDHc from E. coli. It should be noted that E2pLD has three
lipoyl domains. Then, 2-OG will be added and ESI-MS will be performed to detect
whether reductive acylation has occurred. It was previously demonstrated that E1o-E2p-E3
was active with 2-OG in the overall reaction. When 2-OV was substituted for 2-OG, the
reconstituted complex was inactive in the overall reaction. In addition, similar analysis was
carried out with the E1o H298D variant, which showed higher activity toward the
unnatural substrate 2-OV.
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3.2 Materials
2-Oxoglutarate and 2-oxovalerate, formic acid and methanol were from Sigma-Aldrich.
Restriction enzymes were purchased from Invitrogen. Lipoyl protein ligase, ATP and
DL--lipoic acid were from USB. Primers were obtained from Fisher. E. coli strain
JW0715 containing the plasmid pCA24N encoding the OGDHc-E1 (E1o) component
[ASKA clone (-)] was obtained from National Bio Resource Project (NIG, Japan).
Amicon® Ultra-4 Centrifugal Filter Units are from EMD Millipore. Vivaspin 500 units are
from GE Healthcare Biosciences, Piscataway, NJ.

3.3 Methods
3.3.1 Protein Expression and Purification
The expression and purification of E1o, E1o H298D, E2o, and E3 were described in
Chapter 2.
E. coli cells from a frozen stock, which harbor the plasmid containing E2oLD, were
streaked on LB agar plates containing chloramphenicol (30 g/mL) and incubated at 37 °C
overnight. A single colony was used to inoculate 20 mL LB containing chloramphenicol
(30 g/mL). The overnight culture was used to inoculate 1 L of LB medium containing
chloramphenicol (30 g/mL) and lipoic acid (0.3 mM). The culture was induced with
IPTG (1.0 mM) when the OD600 reached 0.6 and incubated at 37 oC for 5 h with shaking at
250 RPM overnight. The cells were centrifuged at 4400 g at 4 °C, and the pellets were
stored at -20 °C.
All subsequent steps were carried out at 4 °C. The cells were resuspended in
KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M), EDTA (0.50 mM), DTT (1.0 mM),
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benzamidine hydrochloride (1.0 mM), PMSF (1.0 mM), lysozyme (0.6 mg/mL) and
incubated on ice for 20 min. The cells were sonicated for 4 min (10 s pulsar “on” and 10 s
pulsar “off”) using the Sonic Dismembrator Model 550 (Fisher Scientific). The lysate was
centrifuged at 30,000 g at 4 °C for 30 min. The supernatant was applied to a Ni Sepharose
6 Fast Flow Column (GE Healthcare) that was equilibrated with KH2PO4 (20 mM, pH 7.2),
which contained NaCl (0.5 M), EDTA (0.50 mM), DTT (1.0 mM), benzamidine
hydrochloride (1 mM). The enzyme was eluted with KH2PO4 (20 mM, pH 7.2) containing
NaCl (0.5 M), imidazole (150 mM), and EDTA (0.5 mM). Fractions with enzyme were
combined, dialyzed against KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M), EDTA
(0.5 mM) and benzamidine hydrochloride (1.0 mM). Next, the enzyme was concentrated
by ultrafiltration with a cutoff of 30 kDa. The purity was confirmed by SDS-PAGE.
E2pLD was purified as described previously [62] except that no DL-α-lipoic acid
was added to cell culture.
3.3.2 Lipoylation of E2pLD
As shown by ESI-FTMS, the purified E2oLD was fully lipoylated, while E2pLD was
completely unlipoylated. To achieve full lipoylation of E2pLD, the lipoylation reaction for
E2pLD was performed in vitro with E. coli lipoyl protein ligase [78]. E2pLD (50 μM) was
incubated in ammonium bicarbonate (20 mM, pH 7.0) containing ATP (1.2 mM), MgCl2
(1.2 mM), DL-α-lipoic acid (0.6 mM), lipoyl protein ligase (0.8 μM,) for 1 h at room
temperature.

49

3.3.3 Reaction of the Enzyme with Substrates
The purified proteins (E2oLD, wild-type E1o, and E1o H298D) in KH2PO4 buffer (20 mM,
pH 7.2) and lipoylated E2pLD were dialyzed against ammonium bicarbonate (20 mM, pH
7.0) buffer by Vivaspin 500 units (3K MWCO for E2oLD and E2pLD; 10K MWCO for
wild-type E1o and E1o H298D). Wild-type E1o or E1o H298D (1 or 30 M) and E2oLD or
E2pLD (30 M) were incubated in ammonium bicarbonate (20 mM, pH 7.0) containing
MgCl2 (0.1 mM), thiamin diphosphate (ThDP, 0.05 mM) and substrate (2-OG or 2-OV, 5
mM) for 10 min at room temperature.
3.3.4 Measurement of the Acylation of E2oLD and E2pLD with ESI-FTMS
Mass spectrometric analysis was carried out on a Bruker Daltonics Apex Ultra 7.0 FT-MS
Mass Spectrometer. All protein samples were diluted into 1µM with a buffer consisting of
a 50: 50: 0.1 (v: v: v) mixture of methanol, water and formic acid. The samples were
introduced into the mass spectrometer through a KD Scientific KDS-100 syringe pump at a
flow rate of 120 µL/h. Mass spectra were acquired with electrospray in the positive
ionization mode. To achieve high accuracy in the mass measurement, the mass
spectrometer was calibrated using Agilent ES Tuning Mix over a mass to charge ratio of
300 to 3,000. The acquired mass spectra were analyzed and deconvoluted with Bruker
Daltonics DataAnalysis 4.0.
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3.4 Results and Discussion
3.4.1 ESI-MS Analysis of E2oLD in the Reaction with E1o and 2-OV
Here, the most abundant isotopic mass is used for mass comparison. The theoretical mass
was calculated by Bruker Daltonics IsotopePattern 1.3, and the experimental mass was
read from Bruker Daltonics DataAnalysis 4.0.
As a control, it was shown by ESI-MS that E1o, E2oLD and 2-OG forms
succinylated E2oLD (Figure 3.4). The theoretical mass difference between succinylated
E2oLD (11523.82 Da) and E2oLD (11422.82 Da) is 101.00 Da. The experimental value
was 100.01 Da. Next, E1o, E2oLD, and 2-OV were incubated together and the reaction
mixture was analyzed by ESI-MS. E2oLD was reductively butyrylated by E1o (Figure
3.5). The theoretical mass difference between butyrylated E2oLD (11493.85 Da) and
E2oLD (11422.85 Da) was 71.85 Da. The experimental value is 71.85 Da. However,
E1o-E2o-E3 could not produce NADH in the overall reaction with 2-OV. Hence, the
reaction is stopped in E2oCD, i.e., the catalytic center responsible for forming acyl-CoA
from acyl-dihydrolipoyl-E2o would not accept the butyryl group. (Figure 3.5)
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Figure 3.4 Mass Spectrum of Succinylated E2oLD Produced by E1o and 2-OG.

Figure 3.5 Mass Spectrum of Butyrylated E2oLD Produced by E1o and 2-OV.
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3.4.2 ESI-MS Analysis of E2oLD in the Reaction with H298 E1o and 2-OV
It was previously shown that His298Asp E1o reconstituted with E2o-E3 produces NADH
in the overall reaction with 2-OG. As control, His298Asp E1o, E2oLD, and 2-OG
produced succinylated E2oLD (Figure 3.6). The experimental value for the difference of
succinylated E2oLD (11422.85 Da) and E2oLD (11522.86 Da) was 100.01 Da, is in
agreement with the theoretical value. Next, His298Asp E1o, E2oLD, and 2-OV were
incubated together and the reaction mixture was analyzed by ESI-MS. E2oLD was
reductively butyrylated by E1o (Figure 3.7) and the experimental value 71.05 Da, which is
in agreement with the theoretical value. However, His298Asp E1o-E2o-E3 could not
produce NADH in the overall reaction. Hence, the reaction is stopped at E2oCD.

Figure 3.6 Mass Spectrum of Succinylated E2oLD Produced by His298Asp E1o and
2-OG.
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Figure 3.7 Mass Spectrum of Butyrylated E2oLD Produced by His298Asp E1o and 2-OV.

3.4.3 ESI-MS Analysis of E2pLD in the Reaction with His298Asp E1o and 2-OV
It was previously shown E1o-E2p-E3 and His298Asp E1o-E2p-E3 were able to produce
NADH in the overall reaction with 2-OG, but the reactions occurred at a slow rate. On the
other hand, E1o-E2p-E3 and His298Asp E1o-E2p-E3 did not generate NADH in the
overall reaction with 2-OV or it generate too little to be detected.
E1o, E2pLD, and 2-OG were incubated and the reaction mixture was analyzed by
ESI-FTMS. E2pLD can be reductively succinylated by wild-type E1o (Figure 3.8) or by
His298Asp E1o (Figure 3.9).
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Figure 3.8 Mass Spectrum of Succinylated E2pLD Produced by E1o and 2-OG.

Figure 3.9 Mass Spectrum of Succinylated E2pLD Produced by His298Asp E1o and
2-OG.

55

E1o, E2pLD, and 2-OV were incubated and the reaction mixture was analyzed by
ESI-FTMS. No reductive butyrylation on E2pLD was observed with wild-type E1o
(Figure 3.10) or with His298Asp E1o (Figure 3.11). These results further support the
conclusions in Chapter 2. E1o-E2p-E3 forms NADH in the overall reaction with 2-OG,
but the complex does not form NADH with 2-OV. Hence, E2p requires engineering to
accept unnatural substrates. In addition, it was shown that E1p has strict substrate
specificity for the natural substrate. This demonstrates that the E1p and E2p components
are not a good starting point for synthesizing derivatives of CoA.

Whereas, E1o,

His298Asp, and E2oLD have a broad specificity and only the E2oCD domain needs
optimization.

Figure 3.10 Mass Spectrum of the Product of a Reaction with E1o, E2pLD and 2-OV.
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Figure 3.11 Mass Spectrum of the Product Resulting from a Reaction of His298Asp E1o,
E2pLD and 2-OV.

3.5 Conclusions
In conclusion, E1o and His298Asp E1o can be reductively succinylate and butyrylate
E2oLD with 2-OG and 2-OV, respectively. These results were confirmed with ESI-FTMS.
However, NADH production was not detected for 2-OV in the overall reaction with either
E1o-E2o-E3 or His298Asp E1o-E2o-E3. Therefore, butyryl transfer from the lipoyl
domain to the catalytic domain is hindered. The E1p and E2p components from PDHc
both require engineering to be used in the synthesis of unnatural CoA derivatives.
However, only the E2oCD domain from OGDHc requires optimization.

Therefore,

OGDHc or variants of OGDHc are a suitable starting point to form unnatural CoA
derivatives.
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CHAPTER 4
INTERCHAIN SUCCINYL TRANSFER IN THE E2 COMPONENT OF THE
ESCHERICHIA COLI 2-OXOGLUTARATE DEHYDROGENASE COMPLEX

4.1 Introduction
For the 2-oxoglutarate dehydrogenase complex (OGDHc) from Escherichia coli, a
stoichiometry of 6 E1o dimers: 8 E2o trimers: 6 E3 dimers was proposed, [7, 15, 79, 80].
All the subunits of E2o have a single lipoyl domain (LD) and catalytic domain (CD). The
LD is succinylated by E1o and then the succinyl group is transferred to the CD. In the CD,
the succinyl group is transferred to CoA producing succinyl-CoA. LD mobility is afforded
by a flexible Ala-Pro rich linker between the LD and CD [17]. Succinyl transfer to the CD
domain may occur through an intrachain (Figure 4.1 A) or interchain (Figure 4.1 B)
pathway.

In this chapter, the possibility of interchain transfer will be determined.
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A.

B.

Figure 4.1 Succinyl Group Transfer in E. coli E2o Component. A: Intrachain Succinyl
Group Transfer. B: Interchain Succinyl Group Transfer (Gray: Sub-complex of E. coli E1o
and E3 Component. Green: LD of E. coli E2o Component. Orange: CD of E. coli E2o
Component).

Two E2o variants were constructed by site directed mutagenesis.
1. The E2o domain alone (E2oLD). This construct does not have the CD domain (Figure
4.2)
2. E2o with a lysine to alanine substitution at position 43 (E2oK43A). This variant is
incompetent towards posttranslational ligation of lipoic acid. Therefore, it cannot be
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reductively succinylated by E1o.

Figure 4.2 The Lipoyl Domain of the E2o Component of E. coli OGDHc. Lys43 Side
Chain is shown as Sticks.

A crossover experiment was designed to test this hypothesis. The overall reaction
of OGDHc is the following (Equation 4.1).

2-oxoglutarate + CoA + NAD+ → succinyl CoA + CO2 + NADH

(4.1)

First, E1o, E2oLD and E3 will be reconstituted and no NADH should be produced
in the overall reaction of OGDHc (Figure 4.3 A). Second, E1o, E2oK43A and E3 will be
reconstituted and it is also expected not to produce NADH in the overall reaction (4.3 B).
Finally, E2oLD will be added to the reconstituted complex that contains E1o, E2oK43A
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and E3. As a result, E2oLD should rescue the activity, and NADH should be produced.
A.

B.

C.

Figure 4.3 Crossover Experiment of Interchain Succinyl Transfer of E2o. Gray: E1o and
E3 Components of OGDHc. Green: Reconstituted E2o Complexes.
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4.2 Materials
Thiamin diphosphate (ThDP), dithiothreitol, and isopropyl--D-thiogalactopyranoside
(IPTG) were from U.S. Biochemical Corp. NAD+, coenzyme A (CoA), and succinyl
coenzyme A (succinyl CoA), phenylmethanesulfonyl fluoride (PMSF) were from
Sigma-Aldrich. Restriction enzymes were purchased from Invitrogen. Primers were
procured from Fisher.
DNA sequencing was done at the Molecular Resource Facility of the New Jersey
Medical School (Newark, NJ).

4.3 Methods
4.3.1 Site Directed Mutagenesis
Site-directed saturation mutagenesis libraries were constructed using a modified
QuikChange procedure for lipoyl domain of E2oLD and E2oK43A variants. A typical 50
L reaction contained 10x PfuUltra buffer, dNTP (0.2 mM) and PfuUltra DNA polymerase
(1 unit), pCA24N encoding the E2o subunit, and primers are shown in Table 4.1.

Table 4.1 List of Primers for Creating Variants of E2o
No
1
2
3
4

Site
5’
Primers
3’
E2oLD_F
GGTAAAGAAACCAGCGCCTAATCTGAAGAGAAAGCGTCC
E2oLD_R
GGACGCTTTCTCTTCAGATTAGGCGCTGGTTTCTTTACC
E2oK43A_F
GAAATCGAAACTGACGCGGTGGTACTGGAAGTACCG
E2oK43A_R
CGGTACTTCCAGTACCACCGCGTCAGTTTCGATTTC

62

The PCR product was transformed into BL21 E. coli competent cells. The plasmid was
isolated and the gene was confirmed by DNA sequencing. Frozen stock of cells were
stored at -80 oC.
4.3.2 Protein Expression and Purification
The protein expression and purification of E1o, E2o, and E3 were described in Chapter 2.
The E2oK43A variant was purified using same method as wild type E2o. The purification
of E2o LD was described in Chapter 3. The E2oK43A variant was overexpressed and
purified using the procedure developed for wild type E2o. Purified proteins were stored at
-20 °C.
4.3.3 Measurement of the OGDHc Activity
Overall activity of the OGDHc consisting of E2o and its variants was measured after
reconstitution of the complex with independently expressed E1o and E3 components. A
Varian DMS 300 spectrophotometer was used to monitor the 2-oxoglutrate dependent
reduction of NAD+ at 340 nm. First, E2oK43A was titrated with increasing concentrations
of E2oLD in order to determine at optimal mass ratio of E2oLD:E2oK43A (0.25:1 to
2.5:1). Solutions that contain E2oLD and E2oK43A were preincubated at room temperate
for 20 min in KH2PO4 (20 mM, pH 7.2) containing NaCl (0.5 M). Then, E1o and E3 were
added and incubated for 20 min at room temperature in the same buffer. The assay medium
contained: 0.1 M Tris-HCl (pH 8.0), MgCl2 (1.0 mM), ThDP (0.2 mM), NAD+ (2.5 mM)
and CoA (0.13 mM). The reaction was initiated by the addition of 2-OG (2.0 mM). The
initial steady state velocities were determined from the progress curves recorded at 340 nm
and 30 oC. One unit of activity is defined as the amount of NADH produced (mol/min/mg
of complex). Overall activity for wild type OGDHc was described in Chapter 2. The
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overall activity of reconstituted complex containing E1o/E2oK43A/E3 E1o/E2oLD/E3
was identical to that of wild type OGDHc.

4.4 Results and Discussion
4.4.1 Substitutions of Lys43Ala E2o and E2oLD Affected the Overall OGDHc
Activities
The overall activity of reconstituted complex, which contains E1o, E2oLD, and E3 did not
produce detectable amounts of NADH. It is expected that when E1o, E2oK43A, and E3 are
reconstituted together, the complex should not show NADH production. However, NADH
was generated (1.7%) at a low rate (Table 4.2), and this value was used as the baseline.
4.4.2 Complementation of E2oLD with E2oK43A
E2oK43A was titrated with increasing concentrations of E2oLD, and then E1o and E3
were added to form a reconstituted complex (Figure, 4.4, Table 4.2). NADH was formed
in the overall reaction above the baseline. Maximum activity of 4.9 % above the
background was found with a ratio 0.5 E2oLD: 1.0 E2oK43A.
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Table 4.2 Overall OGDHc Activity of E2oLD/Lys43Ala with Various Mass Ratios
Enzyme

Activity (units/mg complex)

E1o : E2o : E3
E1o : E2oLD: E3
E1o : E2oK43A: E3
E1o : (E2oLD : E2oK43A = 0.25:1): E3

2.06
No Activity
0.035 (1.7%)
0.046 (2.2%)

E1o : (E2oLD : E2oK43A = 0.5:1): E3

0.101 (4.9%)

E1o : (E2oLD : E2oK43A=1:1) : E3

0.093 (4.5%)

E1o : (E2oLD : E2oK43A=2:1) : E3

0.062 (3.0%)

E1o : (E2oLD : E2oK43A=2.5:1) : E3

0.074 (3.6%)
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0.30
E2oLD : E2oK43A = 0.25 :1
E2oLD : E2oK43A = 0.5 :1
E2oLD : E2oK43A = 1 :1
E2oLD : E2oK43A = 2 :1
E2oLD : E2oK43A = 2.5 :1
E1o : E2oK43A: E3
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Figure 4.4 Activity Assay for E2o Variants Reconstituted with E1o and E3. Mixtures of
E2oK43A and E2oLD in Various Mass Ratios were Incubated and E1o and E3 were Added
Enabling Use of the NADH Production Assay for Overall Activity of the Complex.
These results clearly show that E2oLD was capable of rescuing the crippled
E2oK43A variant. Therefore, an interchain mechanism is likely between two different
E2o subunits.
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CHAPTER 5
CARBOLIGASE REACTION OF THE E1 COMPONENT OF THE
2-OXOGLUTARATE DEHYDROGENASE COMPLEX

5.1 Introduction
Thiamin diphosphate (ThDP)-dependent enzymes have the potential to be used for
chemical synthesis. These enzymes share a common feature in that they catalyze
carboligase reactions [81, 82]. Carboligation is the native activity for several enzymes, but
it is a side reaction for nearly all ThDP-dependent 2-oxo acid dacarboxylases. The Jordan
research group at Rutgers-Newark have previously constructed several active site variants
in yeast pyruvate decarboxylase (YPDC) from Saccharomyces cerevisiae and in the E1
subunit of Escherichia coli pyruvate dehydrogenase complex (E1p), and they are capable
of carrying out such reactions [49]. The E477Q variant of YPDC was an effective acetoin
synthase, while the D28A or D28N variants catalyze acetolactate formation [72]. The
E636Q and E636A E1p active site variants were also created and they also became
acetolactate synthases [50]. Remarkably, although YPDC and E1p both catalyze
decarboxylation of pyruvate in the first step, the opposite enantiomers of acetoin were
produced.
The E1 subunit (E1o) of E. coli 2-oxoglutarate dehydrogenase complex (OGDHc)
also catalyzes carboligation reactions. The central ThDP-bound enamine intermediate
reacts with the electrophilic substrate, which results in the formation of acetoin-like or
acetolactate-like ligated products (Scheme 3).
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Scheme 3 Carboligase Reaction of ThDP-dependent Enzymes from the Central
ThDP-bound Enamine Intermediate.

The E1o component of E. coli OGDHc was reacted with substrates that vary in the
size and functional groups to determine the versatility for carboligase reactions (Figure
5.1).

The products were confirmed by circular dichroism (CD), nuclear magnetic

resonance (NMR) and chiral gas chromatography (GC).
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Figure 5.1 Substrates and Acceptors for Carboligase Reaction by E1o.

5.2 Materials
2-Oxoglutarate, 2-oxovalerate, 2-oxoisovalerate, glyoxylate, ethyl glyoxylate, and
methylglyoxal were from Sigma-Aldrich. Restriction enzymes were purchased from
Invitrogen. Primers were procured from Fisher. E. coli strain JW0715 containing the
plasmid pCA24N encoding the OGDHc-E1 (E1o) component [ASKA clone (-)] was
obtained from National Bio Resource Project (NIG, Japan). Amicon® Ultra-4 Centrifugal
Filter Units are purchased from EMD Millipore.
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5.3 Methods
5.3.1 CD Analysis
CD experiments were carried out on a Chirascan CD spectrometer (Applied Photophysics,
Leatherhead, UK). First, E1o (concentration of active centers = 19 M) in KH2PO4 (20
mM, pH 7.0) containing MgCl2 (2 mM), ThDP (0.2 mM) was incubated overnight with
2-OG (2 mM). Next, the acceptors glyoxylate (1 mM), ethyl glyoxylate (1 mM), or
methylglyoxal (1 mM)) were added and CD spectrum was recorded (reaction 1). Similar
reactions were performed using 2-OV (10 mM, reaction 2) or 2-OiV (10 mM, reaction 3) as
the substrates with the acceptors. The protein was seperated from the carboligase product
using an Amicon® Ultra-4 Centrifugal Filter Units. The filtrate was collected and the CD
spectra were recorded between 260 nm and 400 nm.
5.3.2 NMR Analysis
After CD experiment, the carboligase product was extracted with chloroform. Then,
sodium sulfate was added to remove dry the organic layer. Spectra were recorded on a
Varian 500 MHz INOVA spectrometer at 25 oC. The spectra were record by Hetalben
Patel at Rutgers.
5.3.3 Chiral GC Analysis
Products were extracted from the reaction mixture with choloroform and analyzed by GC.
GC analysis was carried out on a Varian CP-3800 gas chromatograph equipped with a
Chiraldex B-DM chiral column (Astec, Advanced Separation Technologies, Inc.) and a
flame ionization detector at a flow rate of 1.5 ml/min. The enantiomers were assigned
according to their relative retention time. It is known that the (S)-enantiomer interacts
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more favorably with the matrix than the (R)-enantiomer. Hence, the (S)-enantiomer has a
longer retention time.

5.4 Results and Discussion
5.4.1 Acetoin-like Product Formation by E1o with 2-OG and Glyoxylate
No CD band was produced on reacting E1o and 2-OG showing the E1o could not form a
carboligase product with 2-OG alone. The active site may not be large enough to
accommodate a free 2-OG as an acceptor or a racemic mixture was produced. Hence,
glyoxylate, which is a smaller acceptor, was next used.
The reaction of E1o with 2-OG and glyoxylate (Figure 5.2) produced a negative
CD band at 278 nm and positive band at 312 nm (Figure 5.3). The negative band indicates
(R)-acetoin-like product formation (Figure 5.3). The product was confirmed by chiral GC
(Figure 5.4) and 1H NMR (Figure 5.5).

Figure 5.2 The Acetoin-like Product Produced from 2-OG and Glyoxylate.
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Figure 5.3 CD Spectrum of the Compound Produced by E1o (19 M Active Center
Concentration) in the Presence of 2-OG (2 mM), Glyoxylate (1 mM), MgCl2 (2 mM),
ThDP (0.2 mM).

Figure 5.4 Chiral GC of the Product from E1o with 2-OG and Glyoxylate.
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Figure 5.5 1H NMR Spectrum of the Product Produced by E1o with 2-OG and Glyoxylate.

5.4.2 Acetoin-like Product Formation by E1o with 2-OV and Glyoxylate
No CD band was produced when E1o was reacted with 2-OV, showing that the enzyme
could not form a carboligase product from 2-OV alone. The active site may not be large
enough to accommodate a free 2-OV as an acceptor or a racemic mixture was produced.
Again, the acceptor glyoxylate was next tried.
The reaction of E1o with 2-OV and glyoxylate (Figure 5.6) produced a positive CD
band at 278 nm (Figure 5.7). The positive band indicates (S)-acetoin-like product, which
was confirmed by chiral GC (Figure 5.8) and 1H NMR (Figure 5.9).

Figure 5.6 The Acetoin-like Product Produced by E1o from 2-OV and Glyoxylate.
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Figure 5.7 CD Spectrum of the Compound Produced by E1o (19 M Active Center
Concentration) in the Presence of 2-OV (5 mM), Glyoxylate (10 mM), MgCl2 (2 mM), and
ThDP (0.2 mM).

Figure 5.8 Chiral GC of the Product Produced by E1o with 2-OV and Glyoxylate.
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Figure 5.9 1H NMR Spectrum of the Product Produced by E1o with 2-OV and Glyoxylate.
5.4.3 Acetoin-like Product Formation by E1o with 2-OiV and Glyoxylate
No CD band was produced when E1o was reacted with 2-OiV, showing that the enzyme
could not form a carboligase product from 2-OiV itself. The E1o active site may not be
large enough to accommodate a free 2-OiV as acceptor or a racemic mixture was produced.
Again, the acceptor glyoxylate was next tried.
The reaction of E1o with 2-OiV and glyoxylate (Figure 5.10) produced a positive
CD band at 280 nm (Figure 5.11). The positive band indicates an (S)-acetoin-like product,
which was confirmed by chiral GC (Figure 5.12) and 1H NMR (data not shown).

Figure 5.10 The Acetoin-like Product Produced from 2-OiV and Glyoxylate.
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Figure 5.11 CD Spectrum of the Compound Produced by E1o (19 M Active Center
Concentration) in the Presence of 2-OiV (5 mM), Glyoxylate (10 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).

Figure 5.12 Chiral GC of the Product Produced by E1o with 2-OiV and Glyoxylate.
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5.4.4 Acetoin-like Product Formation by E1o with 2-OG and Ethyl Glyoxylate
The reaction of E1o with 2-OG and ethyl glyoxylate (Figure 5.13) produced a negative CD
band at 280 nm (Figure 5.14). The negative band indicates an (R)-acetoin-like product,
which was confirmed by chiral GC (Figure 5.15) and 1H NMR (Figure 5.16).

Figure 5.13 The Acetoin-like Product Produced by E1o from 2-OG and Ethyl Glyoxylate.

Figure 5.14 CD Spectrum of the Compound Produced by E1o (19 M Active Center
concentration) in the Presence of 2-OG (2 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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Figure 5.15 Chiral GC of the Reaction Product Formed by E1o with 2-OG and Ethyl
Glyoxylate.

Figure 5.16 1H NMR Spectrum of the Product Formed by E1o with 2-OG and Ethyl
Glyoxylate.
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5.4.5 Acetoin-like Product Formation by E1o with 2-OV and Ethyl Glyoxylate
The reaction of E1o with 2-OV and ethyl glyoxylate (Figure 5.17) produced a weak
positive band CD band at 280 nm (Figure 5.18). The positive band indicates
(S)-acetoin-like product, which was confirmed by chiral GC (Figure 5.19) and 1H NMR
(Figure 5.20).

Figure 5.17 The Acetoin-like Product Produced Formed by E1o 2-OV and Ethyl
Glyoxylate.
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Figure 5.18 CD Spectrum of the Compound Produced by E1o (19 M Active Center
Concentration) in the Presence of 2-OV (5 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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Figure 5.19 Chiral GC of the Product Formed by E1o with 2-OV and Ethyl Glyoxylate.

Figure 5.20 1H-NMR Spectrum of the Compound Produced by E1o (19 M Active Center
Concentration) in the Presence of 2-OV (2 mM), Ethyl Glyoxylate (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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5.4.6 Acetoin-like Product Formation by E1o with 2-OiV and Ethyl Glyoxylate
The reaction of E1o with 2-OiV and ethyl glyoxylate (Figure 5.21) produced a positive CD
band at 283 nm (Figure 5.22). The positive band indicates (S)-acetoin-like product, which
was confirmed by chiral GC (Figure 5.23) and 1H NMR (Figure 5.24).

Figure 5.21 The Acetoin-like Product Produced by E1o from 2-OiV and Ethyl Glyoxylate.

Figure 5.22 CD Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OiV (5 mM), Ethyl Glyoxylate (10 mM), MgCl2 (2
mM), and ThDP (0.2 mM).
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Figure 5.23 Chiral GC of the Product Formed by E1o with 2-OiV and Ethyl Glyoxylate.

Figure 5.24 1H NMR Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OiV (5 mM), Ethyl Glyoxylate (10 mM), MgCl2 (2
mM), and ThDP (0.2 mM).
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5.4.7 Acetoin-like Product Formation by E1o with 2-OG and Methylglyoxal
The reaction of E1o with 2-OG and methylglyoxal (Figure 5.25) produced a weak positive
CD band at 280 nm (Figure 5.26). The positive band suggests (S)-acetoin-like product,
which was confirmed by chiral GC (Figure 5.27) and 1H NMR (Figure 5.28).

Figure 5.25 The Acetoin-like Product Produced from 2-OG and Methylglyoxal.
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Figure 5.26 CD Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OG (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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Figure 5.27 Chiral GC of the Product Formed by E1o with 2-OG and Methylglyoxal.

Figure 5.28 1H NMR Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OG (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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5.4.8 Acetoin-like Product Formation by E1o with 2-OV and Methylglyoxal
The reaction of E1o with 2-OV and methylglyoxal (Figure 5.29) produced a weak negative
CD band at 280 nm (Figure 5.30). The negative band indicates a (R)-acetoin-like product,
which was confirmed by chiral GC (Figure 5.31) and 1H NMR (Figure 5.32).

Figure 5.29 The Acetoin-like Product Produced from 2-OV and Methylglyoxal.

Figure 5.30 CD Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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Figure 5.31 Chiral GC of the Product Formed by E1o with 2-OV and Methylglyoxal.

Figure 5.32 1H NMR Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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5.4.9 Acetoin-like Product Formation by E1o with 2-OiV and Methylglyoxal
The reaction of E1o with 2-OiV and methylglyoxal (Figure 5.33) produced a weak positive
band CD band at 280 nm (Figure 5.34). The positive band indicates (S)-acetoin-like
product, which was confirmed by chiral GC (Figure 5.35) and 1H NMR (Figure 5.36).

Figure 5.33 The Acetoin-like Product Produced by E1o from 2-OiV and Methylglyoxal.
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Figure 5.34 CD Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OiV (5 mM), Methylglyoxal (10 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).
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Figure 5.35 Chiral GC of the Product Formed by E1o with 2-OiV and Methylglyoxal.

Figure 5.36 1H NMR Spectrum of the Product Formed by E1o (19 M Active Center
Concentration) in the Presence of 2-OiV (2 mM), Methylglyoxal (1 mM), MgCl2 (2 mM),
and ThDP (0.2 mM).

88

5.4.10 Chiral GC Analysis
E1o catalyzes the formation of acetoin-like products for all the reactions in high
enantiomeric excess, as determined with chiral GC (Table 5.1). In addition, E1o
demonstrates the versatility to yield products with different enantiomeric excess. This
enantiomer depends on the substrate and the accepter being used. For example, E1o yields
the (R)-enantiomer with 2-OG as the substrate and glyoxylate acceptor. On the other hand,
(S)-enantiomer is produced with 2-OV as the substrate and glyoxylate as acceptor.

Table 5.1 Enantiomeric Excess of Acetoin-like Product Formed by OGDHc-E1o by Chiral
GCa
Substrate

2-oxoglutarate

2-oxovalerate

2-oxoisovalerate

Acceptor

Enantiomeric excessb

glyoxylate

90.4% (R)

ethyl glyoxylate

80.5% (R)

methyl glyoxal

82.9% (S)

glyoxylate

96.4% (S)

ethyl glyoxylate

(S) c

methyl glyoxal

81.2% (R)

glyoxylate

(S)c

ethyl glyoxylate

(S) c

methyl glyoxal

(S) c

a

See reaction conditions in Material and Methods.
Yield is ~ 100% for all the acetoin products.
c
Due to weak formation of R in GC could not calculate the ee% but clearly shows that S is in excess.
b
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5.5 Conclusions
The ThDP-dependent enzymes are capable of catalyzing a broad range of carboligase
reactions [73]. The variety of activities with respect to substrate range, catalytic activity,
and enantioselectivity is a result of the protein environment surrounding ThDP. E1o of
OGDHc from E. coli was catalyzes carboligase production as a side reaction (Scheme 3).
The E1o is able to use a variety of substrates, which differ in size and polarity. While the
natural substrate 2-OG has a negatively charged carboxylate group, both, 2-OV and 2-OiV
have a hydrophobic tail. Furthermore, 2-OV has a straight chain, while 2-OiV is branched
(Figure 5.1). Next, E1o forms carboligase products with a variety of acceptors, which also
contain a range of size and polarity (Figure 5.1). Finally, the products for the carboligase
reactions are produced with significant ee values. The trend for substrates 2-OV and 2-OiV
reacting with the acceptors glyoxylate and ethyl glyoxylate is to produce the (S)
enantiomer; whereas, 2-OG forms the (R) enantiomer. This may be due to 2-OV and
2-OiV both having hydrophobic tails, while 2-OG is hydrophilic. In contrast, there is no
clear trend for the acceptor methylglyoxal with the three substrates.
The Westerfeld group previously demonstrated formation of carboligase products
using the substrate 2-OV and the acceptors acetaldehyde and glyoxylate and enzymes from
rat and beef heart particulate fractions [83]. However, no ee was reported. In this chapter,
recombinant E1o from E. coli was also shown to form carboligase reactions. NMR
confirmed product formation, and chiral GC and CD established the ee. In addition, it was
shown that E1o is capable of forming esters.

This is important because when the

carboligase reactions produce -ketoacids, these products are unstable and prone to
decarboxylation. E1o of OGDHc can catalyze carboligase reactions from a variety of
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substrate and aldehyde acceptors. These results indicate that E1o is a good starting point
for protein engineering and optimization to synthesize stable chiral intermediates for fine
chemical synthesis.
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APPENDIX
CD TITRATION

Figures A.1 to A.8 show CD titration and dependence of ellipticity of E1o variants with
succinyl phosphonate methyl ester and propionyl phosphinate.

Figure A.1 Dependence of Ellipticity of His298Leu with Succinyl Phosphonate Methyl
Ester at 303nm on the Concentration of Succinyl Phosphonate Methyl Ester.
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Figure A.2 Dependence of Ellipticity of His298Thr with Succinyl Phosphonate Methyl
Ester at 297nm on the Concentration of Succinyl Phosphonate Methyl Ester.
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Figure A.3 CD titration of His298Asp with Succinyl Phosphonate Methyl Ester.

94

Figure A.4 CD titration of His298Val with Succinyl Phosphonate Methyl Ester and
Dependence of Ellipticity at 297 nm on the Concentration of Succinyl Phosphonate Methyl
Ester.
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Figure A.5 CD titration of His298Leu with Propionyl Phosphinate and Dependence of
Ellipticity at 300 nm on the Concentration of Propionyl Phosphinate.

Figure A.6 CD titration of His298Val with Propionyl Phosphinate and Dependence of
Ellipticity at 297 nm on the Concentration of Propionyl Phosphinate.
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Figure A.7 CD titration of His298Thr with Propionyl Phosphinate and Dependence of
Ellipticity at 297 nm on the Concentration of Propionyl Phosphinate.

Figure A.8 CD titration of His260Glu/His298Asn with Propionyl Phosphinate and
Dependence of Ellipticity at 305 nm on the Concentration of Propionyl Phosphinate.
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